Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases

PURPOSE: To examine the evidence on the cost-effectiveness of implementing pharmacogenomics (PGx) in cardiovascular disease (CVD) care. METHODS: We conducted a systematic review using multiple databases from inception to 2018. The titles and abstracts of cost-effectiveness studies on PGx-guided trea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Genet Med
Autors principals: Zhu, Ye, Swanson, Kristi M., Rojas, Ricardo L., Wang, Zhen, St. Sauver, Jennifer L., Visscher, Sue L., Prokop, Larry J., Bielinski, Suzette J., Wang, Liewei, Weinshilboum, Richard, Borah, Bijan J.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group US 2019
Matèries:
Systematic Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7056639/
https://ncbi.nlm.nih.gov/pubmed/31591509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41436-019-0667-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars